"Das Zentralinstitut für Seelische Gesundheit steht für international herausragende Forschung und wegweisende Behandlungskonzepte in Psychiatrie und Psychotherapie, Kinder- und Jugendpsychiatrie, Psychosomatik und Suchtmedizin."

During the past decade, Zentralinstitut für seelische Gesundheit conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zentralinstitut für seelische Gesundheit" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Shire" with 3 trials sponsored, "Central Institute of Mental Health, Mannheim" with 2 trials sponsored, "Charite University, Berlin, Germany" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zentralinstitut für seelische Gesundheit" #1 collaborator was "Bionorica SE" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Janssen Alzheimer Immunotherapy (JAI) Research and Development, LLC" with 1 trials as a collaborator and "Lundbeck GmbH, Ericusspitze 2, 20457 Hamburg" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Zentralinstitut für seelische Gesundheit" are "Schizophrenia" (4 trials), "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (2 trials), "Posttraumatic Stress Disorder" (2 trials) and "Alcoholism" (1 trials). Many other conditions were trialed in "Zentralinstitut für seelische Gesundheit" in a lesser frequency.

Most popular intervention types in "Zentralinstitut für seelische Gesundheit" are "Drug" (21 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "BI 1358894" (3 trials), "BI 409306" (2 trials), "Lisdexamfetamine dimesylate" (2 trials) and "ACC-001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zentralinstitut für seelische Gesundheit" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Zentralinstitut für seelische Gesundheit". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Zentralinstitut für seelische Gesundheit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Zentralinstitut für seelische Gesundheit, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Zentralinstitut für seelische Gesundheit has several departments that took part in Clinical trials: "Department of Addictive Behavior und Addiction Medicine, Central Institute of Mental Health" - 2 trials, "Central Insitute of Mental Health Sleep laboratory Medical Faculty Mannheim/Heidelberg University" - 2 trials